Related Experiment Videos
Soft Tissue Augmentation With Silicone
1Faculty of Medicine (Dermatology), University of California at Los Angeles, Faculty of Medicine (Dermatology), University of Southern California, Los Angeles, California, USA.
Skin Therapy Letter
|February 7, 2001
Summary
Adatosil, a silicone oil approved by the FDA in 1994, can be used for soft tissue augmentation. However, physicians must use caution due to contraindications and application challenges.
Area of Science:
- Biomaterials science
- Dermatology
- Plastic surgery
Background:
- Adatosil is a viscous silicone oil.
- It received FDA approval in 1994 for medical use.
- This approval permits its application in soft tissue augmentation procedures.
Purpose of the Study:
- To inform physicians about the FDA approval of Adatosil for soft tissue augmentation.
- To highlight the necessary precautions and contraindications associated with Adatosil usage.
- To address the technical challenges in applying Adatosil for cosmetic and reconstructive purposes.
Main Methods:
- Review of FDA approval status for Adatosil.
- Analysis of medical literature regarding silicone oil injections.
- Clinical considerations for soft tissue augmentation procedures.
Main Results:
- Adatosil is FDA-approved, removing legal barriers for soft tissue augmentation.
- Physicians are cautioned regarding specific contraindications for Adatosil.
- The technical application of Adatosil presents notable difficulties.
Conclusions:
- Adatosil is a viable option for soft tissue augmentation following FDA approval.
- Careful patient selection and awareness of contraindications are crucial.
- Proper training and technique are essential for successful Adatosil administration.